Petra Schwalie

10PUBLICATIONS
94CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.

|May 01, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.

|Apr 21, 2026
FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

|Mar 12, 2026
Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liver.

Bettina Amberg, Fabian Köchl, Nadine Kumpesa

|Mar 09, 2026
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Sep 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer.

Irene Fusi, Clara Serger, Petra Herzig

Pageof 2

Frequent Collaborators

3 joint publications

Nadine Kumpesa

3 joint publications

Pablo Umaña

2 joint publications

Bart Deplancke

2 joint publications

Hélène Haegel